Van Hulzen Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$260K Buy
+518
New +$249K 0.02% 343
2025
Q1
Sell
-93
Closed -$48.4K 1038
2024
Q4
$48.4K Buy
+93
New +$51.1K ﹤0.01% 511
2023
Q4
Sell
-461
Closed -$233K 320
2023
Q3
$233K Sell
461
-575
-56% -$306K 0.02% 275
2023
Q2
$541K Buy
1,036
+250
+32% +$135K 0.05% 177
2023
Q1
$453K Sell
786
-79
-9% -$44.5K 0.04% 189
2022
Q4
$476K Hold
865
0.05% 180
2022
Q3
$439K Hold
865
0.05% 178
2022
Q2
$470K Hold
865
0.06% 172
2022
Q1
$511K Sell
865
-194
-18% -$111K 0.05% 168
2021
Q4
$707K Hold
1,059
0.08% 145
2021
Q3
$605K Hold
1,059
0.09% 127
2021
Q2
$534K Hold
1,059
0.08% 138
2021
Q1
$483K Sell
1,059
-204
-16% -$97.4K 0.08% 148
2020
Q4
$588K Sell
1,263
-51
-4% -$23.9K 0.09% 124
2020
Q3
$580K Sell
1,314
-2,206
-63% -$911K 0.09% 117
2020
Q2
$1.27M Buy
3,520
+2,200
+167% +$737K 0.19% 80
2020
Q1
$374K Hold
1,320
0.08% 146
2019
Q4
$429K Sell
1,320
-31
-2% -$9.4K 0.08% 167
2019
Q3
$394K Hold
1,351
0.08% 172
2019
Q2
$397K Buy
1,351
+154
+13% +$42.4K 0.09% 163
2019
Q1
$328K Buy
1,197
+36
+3% +$8.96K 0.09% 161
2018
Q4
$260K Buy
1,161
+31
+3% +$7.27K 0.08% 186
2018
Q3
$276K Buy
+1,130
New +$260K 0.07% 177

Other funds holding TMO

Van Hulzen Asset Management's TMO Position: Q2 2026 in Review

Van Hulzen Asset Management opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 518 shares worth $260K. The stake represents 0.02% of the portfolio and ranks #343 among its holdings. This is a return to the name: Van Hulzen Asset Management previously reported a position in TMO as recently as Q4 2024.

Van Hulzen Asset Management first reported a position in TMO in Q3 2018 and has held it in 23 quarters since. The position peaked at $1.27M in Q2 2020. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Van Hulzen Asset Management held 518 shares of Thermo Fisher Scientific worth $260K as of Q2 2026.
  • Thermo Fisher Scientific was a new Van Hulzen Asset Management position in Q2 2026.
  • Thermo Fisher Scientific made up 0.02% of Van Hulzen Asset Management's portfolio in Q2 2026, its #343 holding.
  • Van Hulzen Asset Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 23 quarters since.
  • Van Hulzen Asset Management's Thermo Fisher Scientific position peaked at $1.27M in Q2 2020.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Van Hulzen Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.